🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jodi K. Maranchie

University of Pittsburgh

ORCID: 0000-0002-8534-9468
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table S9 from Cancers as Wounds that Do Not Heal: Differences and Similarities between Renal Regeneration/Repair and Renal Cell Carcinoma

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22364414.v1
Top 100%
0DataRank
Top 100%0 citations

Chand Khanna, Seongjoon Koo, Gadisetti V.R. Chandramouli, Howard H. Yang, Ying Hu +20 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease”.

Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease

New England Journal of Medicine(2021)10.1056/nejmoa2103425
N/A
4.7DataRank · unranked
664 citations

Frede Donskov, Othon Iliopoulos, W. Kimryn Rathmell, Vivek K. Narayan, Benjamin L. Maughan +10 more

Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00389-9
N/A
1.0DataRank · unranked
37 citations

Ane B. Iversen, Vivek Narayan, Benjamin L Maughan, Kathryn E. Beckermann, Stéphane Oudard +10 more

Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00099-3
N/A
0.741DataRank · unranked
27 citations

Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L Maughan, Stéphane Oudard +9 more

Data from Cancers as Wounds that Do Not Heal: Differences and Similarities between Renal Regeneration/Repair and Renal Cell Carcinoma

(2023)10.1158/0008-5472.c.6494180
N/A
0DataRank · unranked
0 citations

Chand Khanna, Seongjoon Koo, Gadisetti V.R. Chandramouli, Howard H. Yang, Ying Hu +20 more

Data from Cancers as Wounds that Do Not Heal: Differences and Similarities between Renal Regeneration/Repair and Renal Cell Carcinoma

(2023)10.1158/0008-5472.c.6494180.v1
N/A
0DataRank · unranked
0 citations

Chand Khanna, Seongjoon Koo, Gadisetti V.R. Chandramouli, Howard H. Yang, Ying Hu +20 more

Supplementary Table S9 from Cancers as Wounds that Do Not Heal: Differences and Similarities between Renal Regeneration/Repair and Renal Cell Carcinoma

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22364414.v1
Top 100%
0DataRank
Top 100%0 citations

Chand Khanna, Seongjoon Koo, Gadisetti V.R. Chandramouli, Howard H. Yang, Ying Hu +20 more

Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2592
N/A
0DataRank · unranked
28 citations

Eric Jonasch, Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L. Maughan +10 more

Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease

Ophthalmology(2024)10.1016/j.ophtha.2024.05.024
N/A
0DataRank · unranked
16 citations

Ramaprasad Srinivasan, Jodi K. Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen, Anders Kruse +19 more

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.022
N/A
0DataRank · unranked
5 citations

Salvatore La Rosa, Tian Zhang, Phillip M. Pierorazio, Laurence Albigès, Kathryn E. Beckermann +19 more

ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma

UNC Libraries(2020)10.17615/e32h-ct35
N/A
0DataRank · unranked
0 citations

Michael W. Kattan, Pheroze Tamboli, Samira A. Brooks, Joel S. Parker, Toni K. Choueiri +10 more

Corrigendum

Ophthalmology(2025)10.1016/j.ophtha.2024.12.032
N/A
0DataRank · unranked
0 citations

Ramaprasad Srinivasan, Jodi K. Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen, A. Kruse +13 more

A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.04.038
N/A
0DataRank · unranked
21 citations

Jodi K. Maranchie, Mark W. Ball, Gennady Bratslavsky, Eric A. Singer, Daniel M. Geynisman

Unraveling the complexity of bladder-centric chronic pain by intravesical contrast enhanced MRI

Continence(2023)10.1016/j.cont.2023.101041
N/A
0DataRank · unranked
9 citations

Jodi K. Maranchie, Rajiv Dhir, Chan‐Hong Moon, Biatta Sholosh, G.K. Balasubramani +6 more